Tác động của hợp chất flavonoid từ Agrimonia pilosa Ledeb trong việc thúc đẩy sự phân hóa tế bào tiền mỡ 3T3-L1 thông qua việc kích hoạt PPARγ một phần

Bays H, Mandarino L, DeFronzo RA (2004) Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocr Metab 89:463–478 Berger JP, Petro AE, Macnaul KL, Kelly LJ, Zhang BB, Richards K, Elbrecht A, Johnson BA, Zhou G, Doebber TW (2003) Distinct properties and advantages of a novel peroxisome proliferator-activated protein γ selective modulator. Mol Endocrinol 17:662–676 Bhalla K, Hwang BJ, Choi JH, Dewi R, Ou L, Mclenithan J, Twaddel W, Pozharski E, Stock J, Girnun GD (2011) N-acetylfarnesylcysteine is a novel class of peroxisome proliferator-activated receptor γ ligand with partial and full agonist activity in vitro and in vivo. J Biol Chem 286:41626–41635 Brozinick JT, McCoid SC, Reynolds TH, Nardone NA, Hargrove DM, Stevenson RW, Cushman SW, Gibbs EM (2001) GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure. Diabetes 50:593–600 Cariou B, Charbonnel B, Staels B (2012) Thiazolidinediones and PPARγ agonists: time for a reassessment. Trends Endocr Metab 23:205–215 Chi YS, Lim H, Park H, Kim HP (2003) Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 66:1271–1278 Christensen KB, Petersen RK, Kristiansen K, Christensen LP (2010) Identification of bioactive compounds from flowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) gamma. Phytother Res 24(S2):S129–S132 Fu Y, Luo N, Lopes-Virella MF (2000) Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages. J Lipid Res 41:2017–2023 Gijsbers L, van Eekelen HD, de Haan LH, Swier JM, Heijink NL, Kloet SK, Man HY, Bovy AG, Keijer J, Aarts JMM, van der Burg B, Rietjens IMC (2013) Induction of peroxisome proliferator-activated receptor gamma (PPARγ)-mediated gene expression by tomato (Solanum lycopersicum L.) extracts. J Agric Food Chem 61(14):3419 Goto TNH, Egawa K, Kim YI, Kato S, Taimatsu A, Sakamoto T, Ebisu S, Hohsaka T, Miyagawa H, Murakami S, Takahashi N, Kawada T (2011) Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist. Biochem J 438:111–119 Huang THW, Kota BP, Razmovski V, Roufogalis BD (2005) Herbal or natural medicines as modulators of peroxisome proliferator activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 96:3–14 Johmura Y (2007) Characterization of novel genes regulating adipocyte differentiation. Yakugaku Zasshi 127:135–142 Lago RM, Singh PP, Nesto RW (2007) Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomized clinical trials. Lancet 370:1129–1136 Lara-Castro C, Fu Y, Chung BH, Garvey WT (2007) Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 18:263–270 Lim Y, Kim I, Seo J (2007) In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes. J Microbiol 45:473–477 Liu X, Zhu LC, Tan J, Zhou XM, Xiao L, Yang X, Wang BC (2014) Glucosidase inhibitory activity and antioxidant activity of flavonoid compound and triterpenoid compound from Agrimonia Pilosa Ledeb. BMC Complement Altern Med 14:12 Masuoka N, Matsuda M, Kubo I (2012) Characterization of the antioxidant activity of flavonoids. Food Chem 131:541–545 Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H (2002) Role of adiponectin in preventing vascular stenosis the missing link of adipo-vascular axis. J Biol Chem 277:37487–37491 Miller AR, Etgen GJ (2003) Novel peroxisome proliferator-activated receptor ligands for type 2 diabetes and the metabolic syndrome. Expert Opin Investig Drugs 12:1489–1500 Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63 Motani A, Wang Z, Weiszmann J, McGee LR, Lee G, Liu Q, Staunton J, Fang Z, Fuentes H, Lindstrom M (2009) INT131: A selective modulator of PPARγ. J Mol Biol 386:1301–1311 Mueller M, Lukas B, Novak J, Simoncini T, Genazzani AR, Jungbauer A (2008) Oregano: a source for peroxisome proliferator-activated receptor gamma antagonists. J Agric Food Chem 56(24):11621–11630 Muoio DM, Newgard CB (2008) Molecular and metabolic mechanisms of insulin resistance and [beta] -cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9(3):193–205 Nugent CPJ, Whitehead JP, Savage D, Wentworth JM, Chatterjee VK, O’Rahilly S (2001) Potentiation of glucose uptake in 3T3-L1 adipocytes by PPAR gamma agonists is maintained in cells expressing a PPAR gamma dominant-negative mutant: evidence for selectivity in the downstream responses to PPAR gamma activation. Mol Endocrinol 15:1729–1738 Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta 380:24–30 Pharmacopoeia Commission of People’s Republic of China (2015) Chinese Pharmacopoeia, Part I. Chemical Industry Press, Beijing, p 102–103 Rasouli N, Kern PA, Elbein SC, Sharma NK, Das SK (2012) Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts. Pharmacogenet Genom 22:484–497 Rau O, Wurglics M, Dingermann T, Abdel-Tawab M, Schubert-Zsilavecz M (2006) Screening of herbal extracts for activation of the human peroxisome proliferator-activated receptor. Pharmazie 61:952–956 Rival Y, Stennevin A, Puech L, Rouquette A, Cathala C, Lestienne F, Dupont-Passelaigue E, Patoiseau J-F, Wurch T, Junquéro D (2004) Human adipocyte fatty acid-binding protein (aP2) gene promoter-driven reporter assay discriminates nonlipogenic peroxisome proliferator-activated receptor γ ligands. J Pharmacol Exp Ther 311:467–475 Saito T, Abe D, Sekiya K (2007) Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes. Biochem Biophys Res Commun 357:371–376 Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45:1661–1669 Schoonjans K, Peinado-Onsurbe J, Lefebvre A-M, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J (1996) PPARalpha and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336–5348 Staels B, Fruchart JC (2005) Therapeutic roles of peroxisome proliferator–activated receptor agonists. Diabetes 54:2460–2470 Storch J, Thumser AE (2000) The fatty acid transport function of fatty acid-binding proteins. Mol Cell Biol 1486:28–44 Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM (1994) mPPAR γ2: tissue-specific regulator of an adipocyte enhancer. Gene Dev 8:1224–1234 Tsao T-S, Burcelin R, Katz EB, Huang L, Charron MJ (1996) Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45:28–36 Vijayalakshmi A, Tripura A, Ravichandiran V (2011) Development and evaluation of anti-acne products from Terminalia arjuna Bark. Int J ChemTech Res 3:320–327 Wu N, Zu Y, Fu Y, Kong Y, Zhao J, Li X, Li J, Wink M, Efferth T (2010) Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium sibiricum L. J Agric Food Chem 58:4737–4743 Wu Z, Bucher N, Farmer SR (1996) Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol Cell Biol 16:4128–4136